Structural and cultural barriers to the adoption of smoking cessation services in addiction treatment organizations

Journal of Addictive Diseases

Volumn 29, Issue 3, 2010, Pages 294-305

  Knudsen, Hannah K ^a   Studts, Jamie L ^a   Boyd, Sara ^a   Roman, Paul M ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

addiction treatment organizations; health services research; Smoking cessation

Indexed keywords

AMFEBUTAMONE; VARENICLINE;

ARTICLE; CULTURAL FACTOR; HEALTH CARE ORGANIZATION; HOSPITAL PERSONNEL; HUMAN; INTERVIEW; NICOTINE REPLACEMENT THERAPY; PROFESSIONAL COMPETENCE; RESOURCE ALLOCATION; SMOKING CESSATION; TELEPHONE; TOBACCO DEPENDENCE; UNITED STATES; COMORBIDITY; CROSS-SECTIONAL STUDY; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; MULTIMODALITY CANCER THERAPY; NEEDS ASSESSMENT; ORGANIZATION; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PROGRAM DEVELOPMENT; PSYCHOLOGY; REHABILITATION CENTER; SMOKING; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UTILIZATION;

COMBINED MODALITY THERAPY; COMORBIDITY; CROSS-SECTIONAL STUDIES; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES RESEARCH; HUMANS; INTERVIEWS AS TOPIC; NEEDS ASSESSMENT; ORGANIZATIONAL CULTURE; PATIENT ACCEPTANCE OF HEALTH CARE; PROFESSIONAL COMPETENCE; PROGRAM DEVELOPMENT; REHABILITATION CENTERS; SMOKING; SMOKING CESSATION; SUBSTANCE-RELATED DISORDERS;

EID: 77954697204     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2010.489446     Document Type: Article

References (41)

1. Reid MS, Fallon B, Sonne S, Nunes EV, Lima J, Jiang H, Tyson C, Hiott R, Arfken C, Bohs R, Orr D, Muir J, Philgren E, LoreeA, Fuller BE, Giordano L, Robinson J, Rotrosen J. Implementation of a smoking cessation treatment study in substance abuse rehabilitation programs: Smoking behavior and treatment feasibility across varied community-based outpatient programs. JAddict Med 2007; 1:154-160
2. Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: What you need to know. J Subst Abuse Treat 2009; 36:205-219
3. Kalman D, Hayes K, Colby SM, Eaton CA, Rohsenow DJ, Monti PM. Concurrent versus delayed smoking cessation treatment for persons in early alcohol recovery: a pilot study. J Subst Abuse Treat 2001; 20: 233-238
4. McCarthy WJ, Collins C, Hser YI. Does cigarette smoking affect drug abuse treatment? J Drug Issues 2002; 32:61-80.
5. Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002; 97:861-869
6. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors 2004; 29:1067-1083
7. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, Melton LJ 3rd.Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996; 275:1097-1103
8. Hser YI,McCarthyWJ, Anglin MD. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Prev Med 1994; 23:61-69
9. Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addictive Behaviors 2003; 28:1323-1331
10. Satre DD, Kohn CS, Weisner C. Cigarette smoking and long-term alcohol and drug treatment outcomes: a telephone follow-up at five years. Am J Addict 2007; 16: 32-37
11. Prochaska JJ, Kevin D, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Clin Consult Psychol 2004; 72:1144-1156.
12. Joseph AM, Willenbring ML, Nugent SM, Nelson DB.Arandomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment. J Stud Alcohol 2004; 65:681-691
13. FioreMC, Jaen CR, Baker TB, BaileyWC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer M, Tommasello AC, Villejo L, Wewers ME. Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, 2008.
14. Friedmann PD, D'Aunno TA, Jin L, Alexander JA. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization? Health Serv Res 2000; 35:443-465
15. Richter KP, Choi WS, McCool RM, Harris KJ, Ahluwalia JS. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatr Serv 2004; 55:1258-1264
16. National Institute on Drug Abuse. Principles of drug addiction treatment: A research-based guide. (NIH publication 00-4180.) Rockville, MD: NIDA, 2000.
17. Guydish J, Passalacqua E, Tajima B, Manser ST. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J. Psychoactive Drugs 2007; 39:423-433
18. Friedmann PD, Jiang L, Richter KP. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. J Subst Abuse Treat 2008; 34:165-172
19. McCool RM, Richter KP, Choi WS. Benefits of and barriers to providing smoking treatment in methadone clinics: Findings from a national study. Am J Addict 2005; 14:358-366.
20. Hahn EJ,Warnick TA, Plemmons S. Smoking cessation in drug treatment programs. J Addict Dis 1999; 18:89-101.
21. Knapp JM, Rosheim CL, Meister EA, Kottke TE. Managing tobacco dependence in chemical dependency treatment facilities: a survey of current attitudes and policies. J Addict Dis 1993; 12:89-104.
22. Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, Zammarelli L, Ziedonis DM, Sears C, McCarty D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat 2007; 32: 53-60.
23. Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Research & Health 2006; 29:228-235
24. Bobo JK,Gilchrist LD. Urging the alcoholic client to quit smoking cigarettes. Addictive Behaviors 1983; 8:297-305.
25. Bobo JK, Slade J, Hoffman AL. Nicotine addiction counseling for chemically dependent patients. Psychiatr Serv 1995; 46:945-947
26. Willenbring ML, Kivlahan D, Kenny M, Grillo M, Hagedorn H, Postier A. Beliefs about evidence-based practices in addiction treatment: A survey of Veterans Administration program leaders. J Subst Abuse Treat 2004; 26: 79-85.
27. Mee-Lee D, Gartner L, Miller MM, Shulman GR, Wilford BB. Patient placement criteria for the treatment of substance-related disorders. Chevy Chase, MD: American Society of Addiction Medicine, 1996.
28. Knudsen HK, Ducharme LJ, Roman PM. Early adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectors. J Subst Abuse Treat 2006; 30:363-373
29. Knudsen HK, Ducharme LJ, Roman PM. Counselor emotional exhaustion and turnover intention in therapeutic communities. J Subst Abuse Treat 2006; 31: 173-180
30. Long JS. Regression models for categorical and limited dependent variables. Thousand Oaks, CA: Sage, 1997.
31. Long JS, Freese J. Regression models for categorical dependent variables using Stata. College Station, TX: StataCorp, 2003.
32. Allison PD. Logistic regression using the SAS system: Theory and application. Cary, NC: SAS Publishing, 1999.
33. Allison PD. Missing data. Thousand Oaks, CA: Sage, 2002.
34. Royston P. Multiple imputation of missing values: Update. The Stata Journal 2005; 5:188-201. (Pubitemid 43708483)
35. Royston P. Multiple imputation of missing values: Update of ice. The Stata Journal 2005; 5:527-536. (Pubitemid 43708457)
36. Ambler G, Omar RZ, Royston P. A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Stat Methods Med Res 2007; 16:277-298
37. Barnard J, Rubin DR. Small sample degrees of freedom with multiple imputation. Biometrika 1999; 86: 948-955
38. Ducharme LJ,Mello HL, Roman PM, Knudsen HK, Johnson JA. Service delivery in substance abuse treatment: reexamining "comprehensive" care. J Behav Health Serv Res 2007; 34:121-136
39. Knudsen HK, Ducharme LJ, Roman PM. The use of antidepressant medications in substance abuse treatment: The public-private distinction, organizational compatibility, and the environment. J Health Soc Behav 2007; 48:195-210.
40. Knudsen HK, Ducharme LJ, Roman PM. The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug Alcohol Depend 2007; 87: 164-174
41. Knudsen HK, Roman PM, Ducharme LJ. Does service diversification enhance organizational survival? Evidence from the private substance abuse treatment system. J Behav Health Serv Res 2005; 32:241-252